logo-loader
LON:SNG

Synairgen PLC

Market:
LON
Market Cap:
£9.03 m
Price
8.25 GBX
Change
0.61%
52 weeks high
18.25
52 weeks low
7.50

In brief

Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.

The business, focused primarily on severe asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic Key Opinion Leader network to discover and develop novel therapies for respiratory disease.

 

Snapshot

  • Focused on respiratory disease
  • Two drug candidates, one developed in-house, one by a partner
  • Financially well set to progress its key asset, analyst says